Dr. Greg A. Gerhardt's lab at the University of Kentucky focuses on developing new treatments for cognitive decline associated with Alzheimer's disease and related dementias. They conduct clinical trials using cell therapy techniques, specifically delivering nerve tissue to repair neural circuits that are affected in these diseases. The lab's research aims to enhance the function of cholinergic neurons in patients with Alzheimer's and related conditions, potentially offering more than just symptom relief.